Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of hepatic regeneration after G-CSF (lenograstim) in patients undergoing portal vein embolization or ligation before liver resection for neoplasia
2010-019379-31Phase 2Terminated
- Sponsor
- Fondazione Centro San Raffaele
- Start
- Mar 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of lenograstim in cholangiocarcinoma (CCA) and colorectal cancer (CRC), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Reduction in dropouts from planned surgery. Started Mar 2010; status: terminated.
02
Drugs
lenograstim
03
Conditions
cholangiocarcinoma (CCA)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2010-019379-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019379-31.